Screener
Seres Therapeutics MCRB Q3 2025 earnings
Reported November 5, 2025 · Before market open
Revenue$351.0KMiss by $7.5M
EPS$0.94Beat by $0.89
Revenue estimate$7.8M
EPS estimate$0.05
Next report
Nov 4, 2026 (in 2 months)Revenue estimate$6.4M
EPS estimate-$1.01
Versus estimates
Revenue
Q2 2026$736.0KBeat by $557.0KQ1 2026$358.0KIn lineQ4 2025$438.0KMiss by $4.9M
Q3 2025$351.0KMiss by $7.5M
Diluted EPS
FAQ
- When did Seres Therapeutics report Q3 2025 earnings?
- Seres Therapeutics (MCRB) reported Q3 2025 earnings on November 5, 2025 before market open.
- What were Seres Therapeutics's Q3 2025 revenue and EPS?
- Seres Therapeutics reported revenue of $351.0K and eps of $0.94 for Q3 2025.
- Did Seres Therapeutics beat estimates in Q3 2025?
- Revenue missed the consensus estimate of $7.8M by $7.5M. EPS beat the consensus estimate of $0.05 by $0.89.
- Where can I find Seres Therapeutics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-265708) and the 10-Q periodic report (0001193125-25-266011) directly on SEC EDGAR. The filing index links above go to sec.gov.
